PARSIPPANY, N.J.--(BUSINESS WIRE)--Feb. 26, 2014--
Pacira
Pharmaceuticals, Inc. (NASDAQ: PCRX) today announced that
Dave Stack, president, chief executive officer and chairman of Pacira
Pharmaceuticals, is scheduled to present at the Barclays Global
Healthcare Conference on Thursday, March 13, 2014, at 9 a.m. ET in
Miami. Mr. Stack is expected to present an overview of the company.
A live audio webcast of the Pacira presentation can be accessed by
visiting the “Investors & Media” section of the company’s website at investor.pacira.com.
A replay of the webcast will be archived on the Pacira website for two
weeks following the presentation date.
About Pacira
Pacira Pharmaceuticals, Inc. (NASDAQ: PCRX) is a specialty
pharmaceutical company focused on the clinical and commercial
development of new products that meet the needs of acute care
practitioners and their patients. The company’s current emphasis is the
development of non-opioid products for postsurgical pain control, and
its lead product, EXPAREL® (bupivacaine liposome injectable suspension),
was commercially launched in the United States in April 2012. EXPAREL
and two other products have utilized the Pacira proprietary product
delivery technology DepoFoam®, a unique platform that encapsulates drugs
without altering their molecular structure and then releases them over a
desired period of time. Additional information about Pacira is available
at www.pacira.com.
Source: Pacira Pharmaceuticals, Inc.
Pacira Pharmaceuticals, Inc.
Jessica Cho, (973) 254-3574
